Norges Bank
BOLD

Norges Bank’s Boundless Bio BOLD Stock Holding History

Norges Bank’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-157,211
Closed -$546K – 1918
2024
Q3 		$546K Hold
157,211
– – ﹤0.01% 1777
2024
Q2 		$608K Buy
157,211
+87,211
+125% +$833K ﹤0.01% 1864
2024
Q1 		$998K Buy
+70,000
New +$998K ﹤0.01% 1794

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Norges Bank's BOLD Position: Q4 2024 in Review

Norges Bank sold out of Boundless Bio (BOLD) in Q4 2024, closing a stake of 157,211 shares — an estimated $546K sold.

Norges Bank first reported a position in BOLD in Q1 2024 and held it in 3 quarters. The position peaked at $998K in Q1 2024. 55 funds tracked by Wall St. Rank hold BOLD as of Q4 2024.

  • Norges Bank reported no remaining Boundless Bio position as of Q4 2024 after selling out during the quarter.
  • Norges Bank sold 157,211 Boundless Bio shares in Q4 2024, an estimated $546K.
  • Norges Bank first reported a position in Boundless Bio in Q1 2024 and held it in 3 quarters.
  • Norges Bank's Boundless Bio position peaked at $998K in Q1 2024.
  • 55 funds tracked by Wall St. Rank held Boundless Bio as of Q4 2024.

Based on Norges Bank's 13F filing for Q4 2024, filed 12 Feb 2025.